Types of Chronic Respiratory Diseases (CRD) and Treatment Options
Chronic Respiratory Disease (CRD) is one of the leading health challenges worldwide causing significant mortality and morbidity. It comprises a large number of diseases such as Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnea Syndrome, Asthma, Cystic Fibrosis, Allergic Rhinitis, and others.
The prevalence of CRD has increased over the past few decades. As per the WHO, “the global prevalence of COPD was 251 million in 2016 and an estimated 3.17 million deaths were caused by the disease in 2015 (that is, 5% of all deaths globally in that year)”.
Despite significant research and development related to screening, diagnosis, and treatment of Chronic Respiratory Diseases (CRDs), the prevalence is continuing to rise at an alarming rate. Some of the factors such as air pollution, tobacco consumption (smoking), occupational chemicals, poor diet and nutrition, exposure to dust, and many others have led to a dramatic increase in CRD.
However, to provide effective therapeutics options some of the key companies in the Chronic Respiratory Diseases (CRD) Treatment Market such as Inmunotek, Sanofi, Regeneron, Amgen, and others are actively engaged in the development of therapies.
For more details, visit: Types of Chronic Respiratory Diseases (CRD) and Treatment Options